13F filer · CIK 1507673
RP Management, LLC
New York, NY · filing since Q4 2018 · last filing Aug 6, 2025
Reported value
$0
$-138.8M vs prior
Positions
1
New / sold out
1 / 4
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $138.8M
Top-10 weight
–
Biggest buys vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | N/A | 0 | – | – |
Biggest sells vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | BIOHAVEN LTD | -2,936,507 | -100.0% | $-70.6M |
| Sold out | CYTOKINETICS, INC | -980,392 | -100.0% | $-39.4M |
| Sold out | BIOCRYST PHARMACEUTICALS INC | -3,846,154 | -100.0% | $-28.8M |
| Sold out | VIRACTA THERAPEUTICS INC | -3,700 | -100.0% | $-74 |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | N/AN/A | 0 | $0 | – |